Podcast Episodes
Back to SearchDrug Launch Success In A Changing Commercial Landscape With ACMA's William Soliman, Ph.D.
Episode 310
We love to hear from our listeners. Send us a message.
On this week's episode of the Business of Biotech, William Soliman, Founder and CEO of the Acc…
2 months, 1 week ago
The Editors' Roundtable: A Midyear Look At The 2026 Life Sciences Industry
Episode 309
We love to hear from our listeners. Send us a message.
On this week's episode of the Business of Biotech, Tyler Menichiello, chief editor at Bioproce…
2 months, 2 weeks ago
Derisking CNS Drug Development With Tortugas Neuroscience's Jeff Jonas, M.D.
Episode 308
We love to hear from our listeners. Send us a message.
On this week's episode of the Business of Biotech, Jeff Jonas, M.D., CEO of Tortugas Neuroscie…
2 months, 3 weeks ago
Rare Disease Drug Commercialization With Zevra Therapeutics' Neil McFarlane
Episode 307
We love to hear from our listeners. Send us a message.
On this week's episode of the Business of Biotech, Neil McFarlane, CEO at Zevra Therapeutics, …
2 months, 4 weeks ago
Scaling Manufacturing For Personalized Cell Therapies With Cellino's Marinna Madrid, Ph.D.
Episode 306
We love to hear from our listeners. Send us a message.
On this week's episode of the Business of Biotech, Marinna Madrid, Ph.D., Cofounder, Board Mem…
3 months ago
Building A New Antibody Discovery Platform With Infinimmune's Wyatt McDonnell, Ph.D.
Episode 305
We love to hear from our listeners. Send us a message.
On this week's episode of the Business of Biotech, Wyatt McDonnell, Ph.D., cofounder and CEO a…
3 months, 1 week ago
From Partnered ASO Therapies To A Wholly-Owned Pipeline With Ionis's Brett Monia, Ph.D.
Episode 304
We love to hear from our listeners. Send us a message.
On this week's episode of the Business of Biotech, Brett Monia, Ph.D., CEO at Ionis Pharmaceut…
3 months, 2 weeks ago
Implementing A New CEO Strategy With NervGen's Adam Rogers, M.D. And Rich Macary
Episode 303
We love to hear from our listeners. Send us a message.
On this week's episode of the Business of Biotech, we talk with NervGen leaders Adam Rogers, M…
3 months, 4 weeks ago
The Impact Of FDA Risk On Biotech Rewards With CFO And Board Director Allan Shaw
Episode 302
We love to hear from our listeners. Send us a message.
On this week's episode of the Business of Biotech, five-time public company CFO and seven-time…
4 months ago
Biosimilars And Complex Medicines For All With RNA Therapeutics' Sarfaraz Niazi, Ph.D.
Episode 301
We love to hear from our listeners. Send us a message.
On this week's episode of the Business of Biotech, we speak with Dr. Sarfaraz Niazi, Ph.D., ab…
4 months, 1 week ago